Cellular reducing power (None (no widely accepted abbreviation for "cellular reducing power" as a target))

“Cellular reducing power” refers broadly to the cell’s ability to donate electrons via small molecules known as electron carriers—primarily reduced forms such as NADH and NADPH—in biochemical reactions. This property underpins essential processes including energy generation through cellular respiration and biosynthetic pathways like fatty acid synthesis. Reducing equivalents are generated during catabolic breakdown of nutrients and are consumed during ATP production or anabolic reactions. The maintenance of proper cellular redox balance is critical for normal physiology; disruptions contribute significantly to diseases such as cancer and neurodegeneration. However, “cellular reducing power” itself is not a discrete molecular entity nor an actionable therapeutic target—it represents an emergent property arising from multiple interconnected metabolic pathways involving many different molecules.

Other names

Reducing equivalentsCellular reductive capacityIntracellular redox state

Not applicable for this entry. However, drugs may indirectly affect cellular reducing power by: - Modulating enzymes involved in NAD(P)H production/consumption. - Influencing antioxidant systems. - Affecting mitochondrial function.